Terms: = Thyroid cancer AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270
5 results:
1. CircATXN7 contributes to the progression and doxorubicin resistance of breast cancer via modulating miR-149-5p/hoxa11 pathway.
Wang H; Shan S; Wang H; Wang X
Anticancer Drugs; 2022 Jan; 33(1):e700-e710. PubMed ID: 34845164
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA hoxa11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
Niu X; Yang B; Liu F; Fang Q
Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
[TBL] [Abstract] [Full Text] [Related]
3. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center.
Gan Q; Edeiken BS; Chen MM; Grubbs EG; Busaidy NL; Zafereo M; Perrier ND; Gule-Monroe MD; Krishnamurthy S
J Am Soc Cytopathol; 2019; 8(6):309-316. PubMed ID: 31526696
[TBL] [Abstract] [Full Text] [Related]
4. Long Non-Coding RNA (LncRNA) hoxa11-AS Promotes Breast cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
[TBL] [Abstract] [Full Text] [Related]
5. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution.
Theoharis CG; Schofield KM; Hammers L; Udelsman R; Chhieng DC
Thyroid; 2009 Nov; 19(11):1215-23. PubMed ID: 19888859
[TBL] [Abstract] [Full Text] [Related]
